Clinical Trial

Wearable Insoles for Recurrent Diabetic Ulcer Prevention

Study acronym: WIREDUP
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of the study is to demonstrate the clinical advantages of using the Orpyx SI Sensory Insole (SI) system as an adjunct to standard of care in reducing plantar ulceration in high-risk individuals. The investigators aim to understand participant quality of life, the economic impact and cost-effectiveness of the Orpyx SI insole system, and to evaluate participant engagement and compliance.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-23.
Trial Details
NCT Number NCT07674420
Lead Sponsor Johns Hopkins University
Collaborators: Orpyx Medical Technologies Inc.
Conditions Diabetes, Peripheral Neuropathy, Diabetic Foot Ulcer
Enrollment 17 participants
Start Date 2023-10-17
Primary Completion 2026-11 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2026-07-14